Goldman Sachs Group Inc. Buys Shares of 415,820 Revvity, Inc. (NYSE:RVTY)

Goldman Sachs Group Inc. bought a new stake in Revvity, Inc. (NYSE:RVTY) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm bought 415,820 shares of the company’s stock, valued at approximately $45,453,000.

A number of other hedge funds and other institutional investors also recently bought and sold shares of the business. Parkside Financial Bank & Trust acquired a new position in shares of Revvity during the 4th quarter worth $25,000. Gladius Capital Management LP raised its stake in shares of Revvity by 84.1% during the 3rd quarter. Gladius Capital Management LP now owns 232 shares of the company’s stock worth $26,000 after buying an additional 106 shares during the last quarter. CENTRAL TRUST Co acquired a new position in shares of Revvity during the 4th quarter worth $27,000. Benjamin F. Edwards & Company Inc. acquired a new position in shares of Revvity during the 4th quarter worth $27,000. Finally, ORG Partners LLC acquired a new position in shares of Revvity during the 4th quarter worth $32,000. Institutional investors and hedge funds own 86.65% of the company’s stock.

Analyst Ratings Changes

RVTY has been the subject of several research reports. TD Cowen lifted their price target on Revvity from $123.00 to $130.00 and gave the stock a “buy” rating in a research note on Tuesday, April 30th. Robert W. Baird lifted their price target on Revvity from $126.00 to $127.00 and gave the stock an “outperform” rating in a research note on Tuesday, April 30th. Finally, Jefferies Financial Group initiated coverage on shares of Revvity in a research note on Monday, June 3rd. They issued a “hold” rating and a $115.00 target price for the company. Seven investment analysts have rated the stock with a hold rating and seven have issued a buy rating to the company’s stock. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $117.92.

Revvity Stock Up 0.2 %

RVTY opened at $107.50 on Friday. The company has a debt-to-equity ratio of 0.40, a current ratio of 2.23 and a quick ratio of 1.92. The stock has a market capitalization of $13.26 billion, a price-to-earnings ratio of 88.84, a price-to-earnings-growth ratio of 2.79 and a beta of 1.08. The business has a 50-day moving average of $106.61 and a two-hundred day moving average of $105.57. Revvity, Inc. has a 12 month low of $79.50 and a 12 month high of $131.96.

Revvity (NYSE:RVTY) last issued its earnings results on Monday, April 29th. The company reported $0.98 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.94 by $0.04. Revvity had a return on equity of 7.37% and a net margin of 5.49%. The business had revenue of $649.90 million during the quarter, compared to analysts’ expectations of $646.83 million. During the same quarter in the previous year, the business earned $1.01 EPS. The company’s revenue for the quarter was down 3.7% on a year-over-year basis. On average, research analysts expect that Revvity, Inc. will post 4.65 earnings per share for the current year.

Revvity Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, August 9th. Stockholders of record on Friday, July 19th will be issued a dividend of $0.07 per share. This represents a $0.28 dividend on an annualized basis and a dividend yield of 0.26%. The ex-dividend date is Friday, July 19th. Revvity’s payout ratio is currently 23.14%.

Insider Transactions at Revvity

In related news, insider Joel S. Goldberg sold 4,000 shares of the business’s stock in a transaction that occurred on Friday, June 7th. The stock was sold at an average price of $110.46, for a total transaction of $441,840.00. Following the transaction, the insider now directly owns 36,900 shares of the company’s stock, valued at approximately $4,075,974. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Company insiders own 0.60% of the company’s stock.

Revvity Company Profile

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.